184 related articles for article (PubMed ID: 37338378)
1. Pharmacokinetics of SPR206 in Plasma, Pulmonary Epithelial Lining Fluid, and Alveolar Macrophages following Intravenous Administration to Healthy Adult Subjects.
Rodvold KA; Bader J; Bruss JB; Hamed K
Antimicrob Agents Chemother; 2023 Jul; 67(7):e0042623. PubMed ID: 37338378
[TBL] [Abstract][Full Text] [Related]
2. Plasma and Intrapulmonary Concentrations of ETX2514 and Sulbactam following Intravenous Administration of ETX2514SUL to Healthy Adult Subjects.
Rodvold KA; Gotfried MH; Isaacs RD; O'Donnell JP; Stone E
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30126953
[TBL] [Abstract][Full Text] [Related]
3. Intrapulmonary Pharmacokinetics of Levonadifloxacin following Oral Administration of Alalevonadifloxacin to Healthy Adult Subjects.
Rodvold KA; Gotfried MH; Chugh R; Gupta M; Yeole R; Patel A; Bhatia A
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263070
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Plasma and Intrapulmonary Concentrations of Nafithromycin (WCK 4873) in Healthy Adult Subjects.
Rodvold KA; Gotfried MH; Chugh R; Gupta M; Friedland HD; Bhatia A
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696231
[TBL] [Abstract][Full Text] [Related]
5. Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects.
Rodvold KA; Gotfried MH; Gupta V; Ek A; Srivastava P; Talley A; Bruss J
Antimicrob Agents Chemother; 2022 Jul; 66(7):e0059022. PubMed ID: 35762796
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary disposition of tedizolid following administration of once-daily oral 200-milligram tedizolid phosphate in healthy adult volunteers.
Housman ST; Pope JS; Russomanno J; Salerno E; Shore E; Kuti JL; Nicolau DP
Antimicrob Agents Chemother; 2012 May; 56(5):2627-34. PubMed ID: 22330925
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult Subjects.
Gotfried MH; Horn K; Garrity-Ryan L; Villano S; Tzanis E; Chitra S; Manley A; Tanaka SK; Rodvold KA
Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28696233
[TBL] [Abstract][Full Text] [Related]
8. Meropenem-RPX7009 Concentrations in Plasma, Epithelial Lining Fluid, and Alveolar Macrophages of Healthy Adult Subjects.
Wenzler E; Gotfried MH; Loutit JS; Durso S; Griffith DC; Dudley MN; Rodvold KA
Antimicrob Agents Chemother; 2015 Dec; 59(12):7232-9. PubMed ID: 26349830
[TBL] [Abstract][Full Text] [Related]
9. Plasma and Intrapulmonary Concentrations of Cefepime and Zidebactam following Intravenous Administration of WCK 5222 to Healthy Adult Subjects.
Rodvold KA; Gotfried MH; Chugh R; Gupta M; Patel A; Chavan R; Yeole R; Friedland HD; Bhatia A
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784852
[TBL] [Abstract][Full Text] [Related]
10. Penetration of anti-infective agents into pulmonary epithelial lining fluid: focus on antifungal, antitubercular and miscellaneous anti-infective agents.
Rodvold KA; Yoo L; George JM
Clin Pharmacokinet; 2011 Nov; 50(11):689-704. PubMed ID: 21973267
[TBL] [Abstract][Full Text] [Related]
11. Bronchopulmonary disposition of IV cefepime/taniborbactam (2-0.5 g) administered over 2 h in healthy adult subjects.
Asempa TE; Kuti JL; Nascimento JC; Pope SJ; Salerno EL; Troy PJ; Nicolau DP
J Antimicrob Chemother; 2023 Mar; 78(3):703-709. PubMed ID: 36617636
[TBL] [Abstract][Full Text] [Related]
12. Intrapulmonary pharmacokinetics and pharmacodynamics of meropenem.
Conte JE; Golden JA; Kelley MG; Zurlinden E
Int J Antimicrob Agents; 2005 Dec; 26(6):449-56. PubMed ID: 16280244
[TBL] [Abstract][Full Text] [Related]
13. Comparison of plasma, epithelial lining fluid, and alveolar macrophage concentrations of solithromycin (CEM-101) in healthy adult subjects.
Rodvold KA; Gotfried MH; Still JG; Clark K; Fernandes P
Antimicrob Agents Chemother; 2012 Oct; 56(10):5076-81. PubMed ID: 22802254
[TBL] [Abstract][Full Text] [Related]
14. Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206.
Bruss J; Lister T; Gupta VK; Stone E; Morelli L; Lei Y; Melnick D
Antimicrob Agents Chemother; 2021 Sep; 65(10):e0073921. PubMed ID: 34339267
[TBL] [Abstract][Full Text] [Related]
15. Penetration of GSK1322322 into epithelial lining fluid and alveolar macrophages as determined by bronchoalveolar lavage.
Naderer OJ; Rodvold KA; Jones LS; Zhu JZ; Bowen CL; Chen L; Dumont E
Antimicrob Agents Chemother; 2014; 58(1):419-23. PubMed ID: 24189245
[TBL] [Abstract][Full Text] [Related]
16. Intrapulmonary pharmacokinetics and pharmacodynamics of high-dose levofloxacin in healthy volunteer subjects.
Conte JE; Golden JA; McIver M; Zurlinden E
Int J Antimicrob Agents; 2006 Aug; 28(2):114-21. PubMed ID: 16837169
[TBL] [Abstract][Full Text] [Related]
17. Concentration of enrofloxacin and its active metabolite in alveolar macrophages and pulmonary epithelial lining fluid of dogs.
Hawkins EC; Boothe DM; Guinn A; Aucoin DP; Ngyuen J
J Vet Pharmacol Ther; 1998 Feb; 21(1):18-23. PubMed ID: 9507453
[TBL] [Abstract][Full Text] [Related]
18. Intrapulmonary pharmacokinetics of S-013420, a novel bicyclolide antibacterial, in healthy Japanese subjects.
Furuie H; Saisho Y; Yoshikawa T; Shimada J
Antimicrob Agents Chemother; 2010 Feb; 54(2):866-70. PubMed ID: 19933801
[TBL] [Abstract][Full Text] [Related]
19. Intrapulmonary pharmacodynamics of high-dose levofloxacin in subjects with chronic bronchitis or chronic obstructive pulmonary disease.
Conte JE; Golden JA; McIver M; Little E; Zurlinden E
Int J Antimicrob Agents; 2007 Nov; 30(5):422-7. PubMed ID: 17716873
[TBL] [Abstract][Full Text] [Related]
20. Intrapulmonary pharmacokinetics of linezolid.
Conte JE; Golden JA; Kipps J; Zurlinden E
Antimicrob Agents Chemother; 2002 May; 46(5):1475-80. PubMed ID: 11959585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
